You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Transarterial chemoembolization

Showing 1 - 25 of 589
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CT Imaging for Guiding PA-TACE for HCC

Recruiting
  • Carcinoma, Hepatocellular
  • postoperative adjuvant transarterial chemoembolization
  • Guangzhou, Guangdong, China
    ZhuJiang Hospital of Southern Medical University
Nov 30, 2023

HepaSphere Transarterial Chemoembolization Combined With Hepatic

Not yet recruiting
  • Colorectal Liver Metastases (CRCLM)
  • DEB-TACE plus HAIC
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 25, 2023

HepaSphere Drug-eluting Bead Transarterial Chemoembolization

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • DEB-TACE plus HAIC or HAIC alone
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 19, 2023

Hepatocellular Carcinoma Trial in Nanning (Transarterial chemoembolization, Radiotherapy)

Recruiting
  • Hepatocellular Carcinoma
  • Transarterial chemoembolization
  • Radiotherapy
  • Nanning, Guangxi, China
    Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
Jan 25, 2023

Antibiotic Prophylaxis Trial in Lahore (Ceftriaxone Sodium)

Recruiting
  • Antibiotic Prophylaxis
  • Ceftriaxone Sodium
  • Lahore, Punjab, Pakistan
    Pakistan Kidney and Liver Institute
Dec 8, 2022

Hepatocellular Carcinoma Trial in New Delhi (N Acetylcysteine, Dexamethasone, Placebo)

Not yet recruiting
  • Hepatocellular Carcinoma
  • N Acetylcysteine
  • +2 more
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Sep 8, 2023

Gastric Cancer, Embolization Trial (Transarterial Chemoembolization)

Not yet recruiting
  • Gastric Cancer
  • Embolization
  • Transarterial Chemoembolization
  • (no location specified)
May 17, 2022

Child-Pugh Class A, Child-Pugh Class B, Recurrent Hepatocellular Carcinoma Trial in Palo Alto, Sapporo (radiation, procedure,

Active, not recruiting
  • Child-Pugh Class A
  • +2 more
  • Stereotactic Body Radiation Therapy
  • +3 more
  • Palo Alto, California
  • +1 more
Sep 9, 2022

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Hepatocellular Carcinoma, Bilirubinemia Trial in Minneapolis (Transarterial chemoembolization)

Completed
  • Hepatocellular Carcinoma
  • Bilirubinemia
  • Transarterial chemoembolization
  • Minneapolis, Minnesota
    University of Minnesota
Mar 18, 2022

Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 20, 2022

Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Hepatocellular Carcinoma, Liver Cancer Trial in Seoul (IDA-TACE, DOX-TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Liver Cancer
  • IDA-TACE
  • DOX-TACE
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 27, 2023

Lung Non-Small Cell Carcinoma, Mediastinal Tumor, Pleural Tumor Trial in Duarte (Angiography, Computed Tomography, Ethiodized

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +2 more
  • Angiography
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Hepatocellular Carcinoma Non-resectable, Transarterial Chemoembolization, Tyrosine Kinase Inhibitor Trial in Chengdu (lenvatinib

Enrolling by invitation
  • Hepatocellular Carcinoma Non-resectable
  • +3 more
  • lenvatinib + sindilimab/carrelizumab
  • TACE
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
May 23, 2022

Hepatocellular Carcinoma Trial in Nanjing (cTACE(conventional transarterial chemoembolization))

Recruiting
  • Hepatocellular Carcinoma
  • cTACE(conventional transarterial chemoembolization)
  • Nanjing, Jiangsu, China
    Zhongda Hospital, Southeast University
Dec 28, 2022

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Choroidal and Ciliary Body Melanoma AJCC V8 Trial

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Nov 16, 2022

Colorectal Cancer Trial (TACE protocol, Neoadjuvant Chemotherapy)

Not yet recruiting
  • Colorectal Cancer
  • TACE protocol
  • Neoadjuvant Chemotherapy
  • (no location specified)
Apr 15, 2022

Thrombocytopenia, Hepatocellular Carcinoma Trial in Guangzhou (Avatrombopag)

Not yet recruiting
  • Thrombocytopenia
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 17, 2023

Hepatocellular Carcinoma Trial in Yantai

Completed
  • Hepatocellular Carcinoma
    • Yantai, Shandong, China
      Yuhuangding Hospital
    Sep 16, 2022

    Intermediate Stage of Hepatocellular Carcinoma, Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, Tremelimumab (Cohort A

    Recruiting
    • Intermediate Stage of Hepatocellular Carcinoma
    • Hepatocellular Carcinoma
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    Oct 6, 2022

    Primary Liver Cancer Trial in Shanghai (Embosphere and chemo drug, Polyvinyl alcohol embolization microspheres (Huihe Medical)

    Enrolling by invitation
    • Primary Liver Cancer
    • Embosphere and chemotherapy drug
    • Polyvinyl alcohol embolization microspheres (Huihe Medical) and chemotherapy drug
    • Shanghai, Shanghai, China
      Shanghai Huihe Healthcare Tecnology Co.,Ltd.
    Mar 5, 2023

    Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial

    Not yet recruiting
    • Hepatocellular Carcinoma
    • BCLC Stage B Hepatocellular Carcinoma
    • Atezolizumab Injection
    • +2 more
    • (no location specified)
    Mar 16, 2023

    Inoperable Hepatocellular Carcinoma Trial in Nanjing (TheraSphere™ Yttrium-90 Glass Microspheres, conventional Transarterial

    Recruiting
    • Inoperable Hepatocellular Carcinoma
    • TheraSphere™ Yttrium-90 Glass Microspheres
    • conventional Transarterial Chemoembolization(cTACE)
    • Nanjing, Jiangsu, China
      Zhongda Hospital Southeast University
    Jul 22, 2022

    cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1

    Not yet recruiting
    • HCC
    • +3 more
    • (no location specified)
    Aug 28, 2021